The thorny issue of proactive therapeutic drug monitoring (TDM) for anti-TNF therapy in IBD patients was the subject of a vociferous debate at DDW 2018, ending in no agreement. While noting that Australian clinicians have recently issued a consensus statement offering cautious support for proactive TDM in some situations, the session at DDW 2018 was ...
Conference ‘agrees to disagree’ on proactive therapeutic drug monitoring in IBD
By Michael Woodhead
4 Jun 2018